4.7 Article

Polychlorinated biphenyls influence on autism spectrum disorder risk in the MARBLES cohort

Journal

ENVIRONMENTAL RESEARCH
Volume 171, Issue -, Pages 177-184

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.envres.2018.12.061

Keywords

Polychlorinated biphenyls; Autism; Pregnancy; Ryanodine receptor; Prospective study

Funding

  1. NIH grants from the National Institute of Environmental Health Science, United States [P01-ES011269, R01-ES020392, R01-ES025574, P30-ES023513, R01-ES028089]
  2. Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Centers Network [U54-HD079125, NIH-UL1-TR000002, K12-HD051958]
  3. U.S. Environmental Protection Agency [R-829388, R-833292]
  4. Department of Defense [AR1101941]
  5. UC Davis MIND Institute
  6. EPA STAR [RD-83329201]
  7. NIH [R24-ES028533, P50-MH106438]
  8. Floyd and Mary Schwall Medical Research Fellowship Program predoctoral fellowship [F32-HD088016]
  9. [T32-ES007059]

Ask authors/readers for more resources

Background: Autism spectrum disorder (ASD) is suspected to have environmental and genetic contributions. Polychlorinated biphenyls (PCBs) are environmental risk factors of interest due to their potential as neurodevelopmental toxicants and environmental persistence despite a US production ban in the 1970s. Methods: Participants were mother-child pairs from MARBLES, a high-risk pregnancy cohort that enrolls families who have one child diagnosed with ASD and are planning to have another child. PCB concentrations were measured in maternal blood at each trimester of pregnancy using gas chromatography coupled with triple quadruple mass spectrometry. Concentrations were summed into total PCB and two categories based on function/mechanisms of action: dioxin-like (DL), and ryanodine receptor (RyR)-activating PCBs. Multinomial logistic regression assessed risk of clinical outcome classification of ASD and non-typical development (Non-TD) compared to typically developing (TD) in the children at 3 years old. Results: A total of 104 mother-child pairs were included. There were no significant associations for total PCB; however, there were borderline significant associations between DL-PCBs and decreased risk for Non-TD outcome classification (adjusted OR: 0.41 (95% CI 0.15-1.14)) and between RyR-activating PCBs and increased risk for ASD outcome classification (adjusted OR: 2.63 (95% CI 0.87-7.97)). Conclusion: This study does not provide strong supporting evidence that PCBs are risk factors for ASD or Non-TD. However, these analyses suggest the need to explore more deeply into subsets of PCBs as risk factors based on their function and structure in larger cohort studies where non-monotonic dose-response patterns can be better evaluated.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available